Literature DB >> 10741285

Changes in p21WAF1, pRb, Mdm-2, Bax and Bcl-2 expression in cervical cancer cell lines transfected with a p53 expressing adenovirus.

T G Huang1, S M Ip, W S Yeung, H Y Ngan.   

Abstract

The aim of this study was to provide some insights into the molecular mechanisms involved in p53-dependent apoptosis and growth arrest. Changes in the levels of p53 protein and proteins regulated by p53 were studied in relation to events of the cell cycle and apoptosis in cervical cancer cell lines upon transfection with a p53 expressing adenovirus (Ad5-p53). The post-transfection level of p53 protein in SiHa cells was found to be unchanged during the 24-48 h period. In contrast, the level of p21WAF1 protein was shown to increase to its highest level at 24 h, and decreased gradually up to 48 h after the Ad5-p53 transfection. We further noted that the increase of p21WAF1 was accompanied by G1 arrest at 24 h and the decrease of p21WAF1 was associated with apoptosis at 36-48 h after transfection. An anti-p21WAF1 antibody cross-reactive protein band of approximately 14 kDa was observed in HeLa and C-33A cells when these cells were committed to apoptosis upon Ad5-p53 transfection. In SiHa cells, phosphorylation of pRb was inhibited during the early stage of Ad5-p53 transfection. This was followed by the cleavage of pRb. However, Ad5-p53 transfection did not change the levels of Bax and Bcl-2 proteins. Our results suggested that, Bax and Bcl-2 may not be important for the apoptosis of these cells, whereas cleavage of Rb, and the decrease of p21WAF1 could play important roles in p53-dependent apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10741285     DOI: 10.1016/s0959-8049(99)00247-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  PUMA mediates the apoptotic response to p53 in colorectal cancer cells.

Authors:  Jian Yu; Zhenghe Wang; Kenneth W Kinzler; Bert Vogelstein; Lin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

Review 2.  Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes.

Authors:  Ding-Wu Shen; Lynn M Pouliot; Matthew D Hall; Michael M Gottesman
Journal:  Pharmacol Rev       Date:  2012-06-01       Impact factor: 25.468

3.  Cell cycle regulatory protein expression profiles by adenovirus p53 infection in human papilloma virus-associated cervical cancer cells.

Authors:  Yong-Seok Lee; Su-Mi Bae; Sun-Young Kwak; Dong-Chun Park; Yong-Wook Kim; Soo-Young Hur; Eun-Kyung Park; Byoung-Don Han; Young-Joo Lee; Chong-Kook Kim; Do Kang Kim; Woong-Shick Ahn
Journal:  Cancer Res Treat       Date:  2006-06-30       Impact factor: 4.679

Review 4.  Cisplatin in cancer therapy: molecular mechanisms of action.

Authors:  Shaloam Dasari; Paul Bernard Tchounwou
Journal:  Eur J Pharmacol       Date:  2014-07-21       Impact factor: 4.432

5.  Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.

Authors:  Lu Kong; Qi Hao; Ying Wang; Ping Zhou; Binbin Zou; Yu-xiang Zhang
Journal:  Oncotarget       Date:  2015-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.